Journals / Eurasian Journal of Medicine / 2017 / Cilt: 49 - Sayı: 3

Analysis of Age Distribution and Disease Presentation of 1269 Patients with Sarcoidosis

Sarkoidoz Tanılı 1269 Hastanın Yaş Dağılımı ve Hastalık Prezentasyonuna Göre İncelenmesi

Pages
161–166
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Elderly patients (≥60 years) with sarcoidosis had lower serum ACE levels than younger patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: While the incidence of sarcoidosis peaks between 20 and 39 years, it is comparatively low in elderly subjects.
📊
Key Findings & Data:We sought to determine whether there are age-dependent differences in the demographic and laboratory characteristics of patients with sarcoidosis.Materials and Methods: We retrospectively collected information from our database using the International Classification of Disease (ICD) diagnostic code D86 between 2008 and 2014.
💡
Conclusion & Impact:Elderly patients (≥60 years) with sarcoidosis had lower serum ACE levels than younger patients
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: While the incidence of sarcoidosis peaks between 20 and 39 years, it is comparatively low in elderly subjects. We sought to determine whether there are age-dependent differences in the demographic and laboratory characteristics of patients with sarcoidosis.Materials and Methods: We retrospectively collected information from our database using the International Classification of Disease (ICD) diagnostic code D86 between 2008 and 2014. Patients were divided into three groups: 20–39 years old (Group 1), 40–59 years old (Group 2), and 60–80 years old (Group 3).Results: A total of 3988 patients with code of D86 were included in the study. After the exclusion of noneligible patients, the number of cases in Groups 1, 2, and 3 were 276, 641, and 352, respectively. The groups were compared according to demographic characteristics, ICD diagnostic codes, and laboratory parameters. The ratio of female patients was significantly higher in Group 3 than in Groups 1 and 2 (p=0.000). There was no difference in diagnostic codes of the ICD subgroups between groups (p=0.19). While the level of bloodurea nitrogen was significantly higher in Group 3 patients than in other groups (p=0.000), serum angiotensinconverting enzyme (ACE) values were found to be significantly low in Group 3 (p=0.010). The mean ACE values did not differ between females and males (50.8±39.3 and 59.1±45.5 mg/dL, respectively) (p=0.18).Conclusion: The majority of patients with sarcoidosis were female in all age groups and pulmonary sarcoidosis was the most common presentation of the disease. Elderly patients (≥60 years) with sarcoidosis had lower serum ACE levels than younger patients

Özet

Amaç: Sarkoidoz insidansı 20 ve 39 yaşları arasında pik yapmakta iken, yaşlı olgularda görece düşüktür. Çalışmamızda, sarkoidoz hastalarının demografik ve klinik özelliklerinde yaşa bağlı değişiklikler olup olmadığını belirlemeyi amaçladık.Gereç ve Yöntem: Hastane veritabanımızı kullanarak 2008 ve 2014 yılları arasında, Uluslar arası Hastalık Sınıflama (ICD) tanı kodu D86 olan hastalara ait verileri, retrospektif olarak topladık. Hastalar yaş aralığına göre üç gruba ayrıldı: 20-39 yaş (Grup 1), 40-59 yaş (Grup 2) ve 60-80 yaş (Grup 3).Bulgular: ICD tanı kodu D86 olan toplam 3988 hasta çalışmaya alındı. Uygun olmayan hastalar çalışma dışı bırakıldıktan sonra vaka sayıları Grup 1, 2 ve 3'de sırasıyla 276, 641 ve 352 oldu. Gruplar, demografik özellikleri, ICD tanı kodları ve laboratuar parametrelerine göre karşılaştırıldı. Kadın hasta oranı Grup 3'de Grup 1 ve 2'ye göre anlamlı oranda yüksekti (p=0,000). ICD tanı kodu alt kırılımlarına göre gruplar arasında farklılık yoktu (p=0,19). Kan üre azotu düzeyi Grup 3'de anlamlı oranda yüksek iken (p=0,000), serum anjiyotensinkonverting enzim (ACE) değerleri anlamlı oranda düşük bulundu (p=0,010). Kadın ve erkeklerde ortalama ACE düzeyleri arasında fark yoktu (sırasıyla, 50,8±39,3 ve 59,1±45,5mg/dL) (p=0,18). Sonuç: Tüm yaş gruplarında sarkoidoz hastalarında kadın oranı daha yüksek olup, akciğer sarkoidozu en sık saptanan prezentasyon şekli idi. Yaşlı hastalarda (>=60 yaş) gençlere göre serum ACE düzeyleri daha düşük bulundu

🔖

Cite This Article

KARAKURT, Z., AKSOY, E., OZTAS, S., KOCAK, N. D., AGCA, M. C., AKTURK, U. A., AKKAYA, M. E., GUNGOR, S., YALCİNSOY, M., DUMAN, D., KAVAS, M. (2022). Analysis of Age Distribution and Disease Presentation of 1269 Patients with Sarcoidosis. Eurasian Journal of Medicine, Cilt: 49 - Sayı: 3, 161–166. https://ajindex.com/articles/509412

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. Am J Respir Crit Care Med 1999; 160: 736-55
  2. Birnbaum AD, Rifkin LM. Sarcoidosis: sex-dependent variations in presentation and management. J Ophthalmol 2014; 2014: 236905
  3. Bağcı BA, Bilgin S, Selvi Ü, et al. Yaş faktörünün sarkoidoz üzerine etkisi. İzmir Göğüs Hastanesi Dergisi 2013; 28: 1-11
  4. Morimoto T, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31: 372-9. [CrossRef] 5. Varron L, Cottin V, Schott AM, Brousolle C, Sève P. Late-onset sarcoidosis: a comparative study. Medicine (Baltimore) 2012; 91: 137-43. [CrossRef] 6. Walsh SJ, Rau LM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 2000; 90: 1463-6. [CrossRef] 7. Pollard KM. Gender differences in autoimmunity associated with exposure to environmental factors. J Autoimmun 2012; 38: 177-86. [CrossRef] 8. Cozier YC, Berman JS, Palmer JR, Boggs A, Wise LA, Rosenberg L. Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women’s Health Study. Am J Epidemiol 2012; 176: 635-41. [CrossRef] 9. Jørgensen KT, Pedersen BV, Nielsen NM, Jacobsen S, Frisch M. Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort. J Autoimmun 2012; 38: 81-7. [CrossRef] 10. Lill H, Kliman K, Altraja A. Factors signifying gender differences in clinical presentation of sarcoidosis among Estonian population. Clin Respir J 2016; 10: 282:90
  5. Kowalska M, Niewiadomska E, Zejda JE. Epidemiology of sarcoidosis recorded in 2006- 2010 in the Silesian voivodeship on the basis of routine medical reporting. Ann Agric Environ Med 2014; 21: 55-8
  6. Chevalet P, Clément R, Rodat O, Moreau A, Brisseau JM, Clarke JP. Sarcoidosis diagnosed in elderly subjects: retrospective study of 30 cases. Chest 2004; 126: 1423-30. [CrossRef] 13. Musellim B, Okumus G, Uzaslan E, et al. Epidemiology and distribution of interstitial lung diseases in Turkey. Clin Respir J 2014; 8: 55- 62. [CrossRef] 14. Musellim B, Kumbasar OO, Ongen G, et al. Epidemiological features of Turkish patients with sarcoidosis. Respir Med 2009; 103: 907-12. [CrossRef] 15. Baughman RP, Teirstein